 Todd Hankinson
Concepts (418)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Craniopharyngioma | 17 | 2023 | 65 | 6.310 |
Why?
| | Pituitary Neoplasms | 14 | 2023 | 157 | 4.420 |
Why?
| | Arnold-Chiari Malformation | 11 | 2023 | 30 | 3.160 |
Why?
| | Brain Neoplasms | 23 | 2023 | 979 | 2.990 |
Why?
| | Neurosurgical Procedures | 13 | 2023 | 152 | 2.800 |
Why?
| | Hydrocephalus | 11 | 2023 | 83 | 2.500 |
Why?
| | Brain Stem Neoplasms | 5 | 2016 | 86 | 1.880 |
Why?
| | Magnetic Resonance Imaging | 21 | 2023 | 3053 | 1.790 |
Why?
| | Atlanto-Axial Joint | 7 | 2020 | 12 | 1.700 |
Why?
| | Joint Instability | 7 | 2020 | 162 | 1.660 |
Why?
| | Ganglioglioma | 4 | 2016 | 31 | 1.590 |
Why?
| | Decompression, Surgical | 8 | 2022 | 93 | 1.500 |
Why?
| | Spinal Injuries | 4 | 2022 | 47 | 1.480 |
Why?
| | Child | 71 | 2023 | 18422 | 1.390 |
Why?
| | Glioma | 5 | 2021 | 294 | 1.390 |
Why?
| | Ventriculoperitoneal Shunt | 8 | 2023 | 31 | 1.310 |
Why?
| | Ependymoma | 9 | 2023 | 155 | 1.280 |
Why?
| | Spinal Fusion | 8 | 2021 | 200 | 1.240 |
Why?
| | Pons | 4 | 2016 | 30 | 1.210 |
Why?
| | Sella Turcica | 2 | 2017 | 13 | 1.140 |
Why?
| | Xanthomatosis | 2 | 2017 | 10 | 1.130 |
Why?
| | Dura Mater | 3 | 2021 | 27 | 1.100 |
Why?
| | Child, Preschool | 35 | 2023 | 9119 | 1.090 |
Why?
| | Tomography, X-Ray Computed | 11 | 2022 | 2286 | 1.090 |
Why?
| | Infratentorial Neoplasms | 6 | 2023 | 45 | 1.030 |
Why?
| | Cervical Vertebrae | 7 | 2023 | 104 | 1.020 |
Why?
| | Occipital Bone | 4 | 2018 | 17 | 0.950 |
Why?
| | Cervical Atlas | 2 | 2017 | 4 | 0.920 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2023 | 2 | 0.880 |
Why?
| | Humans | 109 | 2023 | 114709 | 0.860 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2020 | 685 | 0.810 |
Why?
| | Neck Injuries | 1 | 2022 | 18 | 0.810 |
Why?
| | Neural Tube Defects | 4 | 2019 | 61 | 0.800 |
Why?
| | Syringomyelia | 4 | 2021 | 11 | 0.800 |
Why?
| | Infant | 26 | 2023 | 7964 | 0.780 |
Why?
| | Neurosurgery | 3 | 2013 | 26 | 0.770 |
Why?
| | SEER Program | 4 | 2018 | 196 | 0.760 |
Why?
| | Down Syndrome | 2 | 2020 | 335 | 0.750 |
Why?
| | Postoperative Complications | 11 | 2022 | 2128 | 0.740 |
Why?
| | Transcriptome | 7 | 2023 | 726 | 0.720 |
Why?
| | Adolescent | 37 | 2023 | 17855 | 0.710 |
Why?
| | Infant, Newborn | 13 | 2022 | 5047 | 0.710 |
Why?
| | Cerebrospinal Fluid Shunts | 6 | 2023 | 28 | 0.700 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 64 | 0.690 |
Why?
| | Male | 52 | 2023 | 55609 | 0.610 |
Why?
| | Neuroendoscopy | 3 | 2023 | 14 | 0.610 |
Why?
| | Central Nervous System Neoplasms | 2 | 2019 | 126 | 0.580 |
Why?
| | Pituitary Diseases | 1 | 2017 | 22 | 0.560 |
Why?
| | Meningioma | 1 | 2018 | 77 | 0.560 |
Why?
| | Retrospective Studies | 26 | 2023 | 12556 | 0.560 |
Why?
| | Axis, Cervical Vertebra | 2 | 2022 | 7 | 0.550 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 87 | 0.550 |
Why?
| | Female | 53 | 2022 | 59523 | 0.550 |
Why?
| | Intracranial Hemorrhages | 2 | 2020 | 76 | 0.530 |
Why?
| | Skull | 1 | 2017 | 119 | 0.530 |
Why?
| | Treatment Outcome | 22 | 2023 | 9088 | 0.510 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 17 | 0.510 |
Why?
| | Pediatrics | 2 | 2020 | 981 | 0.510 |
Why?
| | Ketorolac | 1 | 2015 | 16 | 0.500 |
Why?
| | EGF Family of Proteins | 1 | 2015 | 15 | 0.500 |
Why?
| | ErbB Receptors | 2 | 2016 | 554 | 0.500 |
Why?
| | Receptor, EphA2 | 1 | 2015 | 19 | 0.490 |
Why?
| | Brain Injuries, Traumatic | 2 | 2019 | 303 | 0.490 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 21 | 0.490 |
Why?
| | Temporal Lobe | 1 | 2015 | 79 | 0.490 |
Why?
| | Receptor, ErbB-3 | 1 | 2015 | 41 | 0.490 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 8 | 0.480 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2020 | 859 | 0.470 |
Why?
| | src-Family Kinases | 1 | 2015 | 88 | 0.470 |
Why?
| | Young Adult | 17 | 2021 | 10472 | 0.470 |
Why?
| | Perioperative Care | 1 | 2015 | 127 | 0.460 |
Why?
| | Reoperation | 5 | 2023 | 514 | 0.460 |
Why?
| | Quality of Life | 5 | 2023 | 2353 | 0.440 |
Why?
| | Data Collection | 2 | 2014 | 620 | 0.440 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.440 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 299 | 0.410 |
Why?
| | Neurology | 1 | 2014 | 85 | 0.410 |
Why?
| | Moyamoya Disease | 2 | 2014 | 14 | 0.410 |
Why?
| | Drug Delivery Systems | 1 | 2015 | 296 | 0.400 |
Why?
| | Spinal Cord Injuries | 2 | 2014 | 174 | 0.400 |
Why?
| | Genomics | 1 | 2016 | 635 | 0.390 |
Why?
| | Urethral Diseases | 1 | 2011 | 18 | 0.390 |
Why?
| | Foreign-Body Migration | 1 | 2011 | 37 | 0.380 |
Why?
| | Scoliosis | 2 | 2019 | 179 | 0.380 |
Why?
| | Brain Injuries | 1 | 2016 | 461 | 0.370 |
Why?
| | Atlanto-Occipital Joint | 2 | 2010 | 4 | 0.370 |
Why?
| | Intracranial Hypertension | 2 | 2010 | 37 | 0.360 |
Why?
| | Cranial Sutures | 1 | 2010 | 9 | 0.360 |
Why?
| | Cephalometry | 1 | 2010 | 28 | 0.350 |
Why?
| | Odontoid Process | 1 | 2010 | 5 | 0.350 |
Why?
| | Craniotomy | 2 | 2008 | 68 | 0.350 |
Why?
| | Esthetics | 1 | 2010 | 37 | 0.350 |
Why?
| | Ventriculostomy | 5 | 2023 | 17 | 0.350 |
Why?
| | Craniosynostoses | 1 | 2010 | 28 | 0.350 |
Why?
| | Societies, Medical | 1 | 2014 | 664 | 0.350 |
Why?
| | Surgeons | 1 | 2014 | 239 | 0.340 |
Why?
| | Patient Discharge | 1 | 2016 | 773 | 0.340 |
Why?
| | Internal Fixators | 1 | 2010 | 36 | 0.340 |
Why?
| | Urinary Bladder | 1 | 2011 | 162 | 0.340 |
Why?
| | Spinal Diseases | 1 | 2010 | 39 | 0.340 |
Why?
| | Brain Stem | 1 | 2010 | 101 | 0.330 |
Why?
| | Anemia, Sickle Cell | 2 | 2014 | 215 | 0.330 |
Why?
| | Cerebral Ventricles | 1 | 2009 | 47 | 0.320 |
Why?
| | Brain | 5 | 2023 | 2371 | 0.320 |
Why?
| | RNA, Messenger | 2 | 2017 | 2553 | 0.320 |
Why?
| | Neuroimaging | 3 | 2020 | 249 | 0.310 |
Why?
| | Adult | 19 | 2021 | 30554 | 0.310 |
Why?
| | Glomus Tumor | 1 | 2008 | 2 | 0.310 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 67 | 0.310 |
Why?
| | Surgical Wound Infection | 3 | 2022 | 248 | 0.300 |
Why?
| | Orbital Neoplasms | 1 | 2008 | 21 | 0.300 |
Why?
| | Cerebral Revascularization | 1 | 2008 | 15 | 0.300 |
Why?
| | Insurance, Liability | 1 | 2008 | 6 | 0.300 |
Why?
| | B7-H1 Antigen | 2 | 2020 | 139 | 0.290 |
Why?
| | Proto-Oncogene Proteins B-raf | 3 | 2019 | 192 | 0.290 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2020 | 194 | 0.280 |
Why?
| | Follow-Up Studies | 8 | 2019 | 4411 | 0.280 |
Why?
| | Medically Underserved Area | 1 | 2008 | 80 | 0.280 |
Why?
| | Granuloma | 2 | 2017 | 83 | 0.270 |
Why?
| | Surgical Flaps | 1 | 2008 | 121 | 0.270 |
Why?
| | Clinical Decision-Making | 2 | 2019 | 268 | 0.270 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 668 | 0.270 |
Why?
| | Prognosis | 7 | 2019 | 3330 | 0.270 |
Why?
| | Autophagy | 2 | 2019 | 235 | 0.260 |
Why?
| | United States | 7 | 2020 | 12186 | 0.240 |
Why?
| | Radiation Injuries | 2 | 2018 | 128 | 0.240 |
Why?
| | Attitude of Health Personnel | 1 | 2011 | 975 | 0.230 |
Why?
| | Brain Concussion | 2 | 2022 | 476 | 0.220 |
Why?
| | Microarray Analysis | 4 | 2017 | 118 | 0.220 |
Why?
| | Combined Modality Therapy | 3 | 2019 | 1121 | 0.210 |
Why?
| | Delayed Diagnosis | 1 | 2023 | 70 | 0.210 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1040 | 0.210 |
Why?
| | Tumor Microenvironment | 3 | 2023 | 430 | 0.210 |
Why?
| | Germinoma | 1 | 2022 | 12 | 0.200 |
Why?
| | Cysts | 1 | 2023 | 93 | 0.200 |
Why?
| | Pineal Gland | 1 | 2022 | 13 | 0.200 |
Why?
| | Pinealoma | 1 | 2022 | 11 | 0.200 |
Why?
| | Hedgehog Proteins | 2 | 2022 | 172 | 0.200 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.200 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 17 | 0.200 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2022 | 1143 | 0.200 |
Why?
| | Endoscopy | 2 | 2015 | 246 | 0.190 |
Why?
| | Spine | 1 | 2023 | 136 | 0.190 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 181 | 0.190 |
Why?
| | Chromosome Aberrations | 2 | 2023 | 135 | 0.190 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.190 |
Why?
| | Traction | 1 | 2021 | 16 | 0.190 |
Why?
| | Middle Aged | 12 | 2020 | 26738 | 0.180 |
Why?
| | Neurosurgeons | 2 | 2019 | 13 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 811 | 0.180 |
Why?
| | Cranial Fossa, Posterior | 1 | 2020 | 16 | 0.180 |
Why?
| | Databases, Factual | 2 | 2016 | 1125 | 0.180 |
Why?
| | Equipment Failure | 1 | 2020 | 106 | 0.170 |
Why?
| | Cerebellar Neoplasms | 1 | 2022 | 130 | 0.170 |
Why?
| | Preoperative Period | 1 | 2020 | 103 | 0.170 |
Why?
| | Sports | 1 | 2022 | 187 | 0.170 |
Why?
| | Medulloblastoma | 1 | 2022 | 172 | 0.170 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1518 | 0.170 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2020 | 59 | 0.170 |
Why?
| | Benchmarking | 1 | 2021 | 161 | 0.170 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 17 | 0.170 |
Why?
| | Prophylactic Surgical Procedures | 1 | 2019 | 5 | 0.170 |
Why?
| | Cohort Studies | 6 | 2021 | 4895 | 0.160 |
Why?
| | Spinal Cord Diseases | 1 | 2019 | 38 | 0.160 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2019 | 31 | 0.160 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.160 |
Why?
| | Cell Line, Tumor | 4 | 2019 | 2711 | 0.160 |
Why?
| | Intracranial Pressure | 1 | 2019 | 48 | 0.160 |
Why?
| | Neoplasm Grading | 2 | 2021 | 242 | 0.160 |
Why?
| | Risk Factors | 7 | 2022 | 8634 | 0.160 |
Why?
| | Hematoma, Subdural | 1 | 2018 | 16 | 0.160 |
Why?
| | Meningomyelocele | 1 | 2019 | 55 | 0.160 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 189 | 0.160 |
Why?
| | Cerebellum | 1 | 2020 | 200 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2020 | 1430 | 0.160 |
Why?
| | Craniospinal Irradiation | 1 | 2018 | 4 | 0.150 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 8 | 0.150 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 188 | 0.150 |
Why?
| | Spinal Curvatures | 1 | 2018 | 3 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2019 | 70 | 0.150 |
Why?
| | Stromal Cells | 1 | 2018 | 97 | 0.150 |
Why?
| | Aged | 7 | 2019 | 19074 | 0.150 |
Why?
| | Skull Neoplasms | 1 | 2017 | 22 | 0.150 |
Why?
| | Aged, 80 and over | 4 | 2018 | 6347 | 0.150 |
Why?
| | Bone Transplantation | 1 | 2018 | 98 | 0.150 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 179 | 0.150 |
Why?
| | Bone Resorption | 1 | 2018 | 73 | 0.150 |
Why?
| | Cyst Fluid | 1 | 2017 | 27 | 0.140 |
Why?
| | Hypophysitis | 1 | 2017 | 2 | 0.140 |
Why?
| | beta Catenin | 1 | 2019 | 219 | 0.140 |
Why?
| | Glioblastoma | 2 | 2010 | 253 | 0.140 |
Why?
| | Nurses | 1 | 2019 | 145 | 0.140 |
Why?
| | Patient Admission | 1 | 2018 | 176 | 0.140 |
Why?
| | Algorithms | 2 | 2022 | 1470 | 0.140 |
Why?
| | Sarcoma, Ewing | 1 | 2017 | 64 | 0.140 |
Why?
| | Re-Irradiation | 1 | 2016 | 8 | 0.140 |
Why?
| | Antineoplastic Agents | 2 | 2018 | 1879 | 0.140 |
Why?
| | Survival Analysis | 2 | 2023 | 1211 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2020 | 515 | 0.140 |
Why?
| | Chloroquine | 1 | 2017 | 52 | 0.140 |
Why?
| | Blood Transfusion | 1 | 2019 | 293 | 0.130 |
Why?
| | Age Factors | 3 | 2020 | 2894 | 0.130 |
Why?
| | Observer Variation | 1 | 2017 | 296 | 0.130 |
Why?
| | Athletic Injuries | 1 | 2022 | 456 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 276 | 0.130 |
Why?
| | Organ Size | 1 | 2017 | 436 | 0.130 |
Why?
| | Delphi Technique | 3 | 2022 | 160 | 0.130 |
Why?
| | Accidents, Traffic | 2 | 2014 | 170 | 0.130 |
Why?
| | Length of Stay | 2 | 2019 | 962 | 0.130 |
Why?
| | Cetirizine | 1 | 2015 | 1 | 0.130 |
Why?
| | Nasal Sprays | 1 | 2015 | 1 | 0.130 |
Why?
| | Ambrosia | 1 | 2015 | 7 | 0.130 |
Why?
| | Cataract | 1 | 2018 | 185 | 0.130 |
Why?
| | Amphiregulin | 1 | 2015 | 21 | 0.120 |
Why?
| | Fluticasone | 1 | 2015 | 87 | 0.120 |
Why?
| | Cytokines | 3 | 2018 | 1841 | 0.120 |
Why?
| | Rhinitis, Allergic, Seasonal | 1 | 2015 | 32 | 0.120 |
Why?
| | Indoles | 1 | 2017 | 304 | 0.120 |
Why?
| | Radiography | 4 | 2023 | 812 | 0.120 |
Why?
| | Logistic Models | 3 | 2019 | 1841 | 0.110 |
Why?
| | Cerebral Veins | 1 | 2014 | 15 | 0.110 |
Why?
| | Sulfonamides | 1 | 2017 | 445 | 0.110 |
Why?
| | Survival Rate | 2 | 2019 | 1644 | 0.110 |
Why?
| | Disease-Free Survival | 1 | 2015 | 620 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3535 | 0.110 |
Why?
| | Neuropsychological Tests | 2 | 2023 | 927 | 0.110 |
Why?
| | Arachnoid Cysts | 1 | 2013 | 6 | 0.110 |
Why?
| | Seasons | 1 | 2015 | 442 | 0.110 |
Why?
| | Central Nervous System Cysts | 1 | 2013 | 11 | 0.100 |
Why?
| | Carcinoma | 1 | 2014 | 198 | 0.100 |
Why?
| | Imaging, Three-Dimensional | 3 | 2017 | 512 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1481 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 1820 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 638 | 0.100 |
Why?
| | Neuroectodermal Tumors, Primitive | 1 | 2012 | 12 | 0.100 |
Why?
| | Cerebral Angiography | 2 | 2014 | 109 | 0.100 |
Why?
| | Up-Regulation | 1 | 2015 | 808 | 0.100 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1075 | 0.100 |
Why?
| | Ischemic Attack, Transient | 2 | 2014 | 62 | 0.100 |
Why?
| | Urethra | 1 | 2011 | 48 | 0.090 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2011 | 52 | 0.090 |
Why?
| | Lymphangioma, Cystic | 1 | 2011 | 4 | 0.090 |
Why?
| | Umbilicus | 1 | 2011 | 14 | 0.090 |
Why?
| | Neurologic Examination | 1 | 2011 | 114 | 0.090 |
Why?
| | Brachial Plexus | 1 | 2011 | 28 | 0.090 |
Why?
| | Teratoma | 1 | 2011 | 92 | 0.090 |
Why?
| | Radiosurgery | 1 | 2014 | 299 | 0.090 |
Why?
| | Third Ventricle | 2 | 2020 | 14 | 0.090 |
Why?
| | Rhabdoid Tumor | 1 | 2011 | 80 | 0.090 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2010 | 4 | 0.090 |
Why?
| | Magnetic Resonance Angiography | 2 | 2014 | 220 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1177 | 0.090 |
Why?
| | Gene Expression | 1 | 2015 | 1421 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2017 | 2765 | 0.080 |
Why?
| | Consensus | 2 | 2022 | 539 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2016 | 800 | 0.080 |
Why?
| | Skull Fracture, Depressed | 1 | 2008 | 1 | 0.080 |
Why?
| | Computer Simulation | 3 | 2021 | 873 | 0.080 |
Why?
| | Head Injuries, Closed | 1 | 2008 | 49 | 0.080 |
Why?
| | Functional Laterality | 1 | 2009 | 198 | 0.080 |
Why?
| | Pia Mater | 1 | 2008 | 4 | 0.080 |
Why?
| | Zygoma | 1 | 2008 | 11 | 0.080 |
Why?
| | Diagnosis, Differential | 2 | 2012 | 1342 | 0.080 |
Why?
| | Topography, Medical | 1 | 2008 | 12 | 0.070 |
Why?
| | Biopsy | 1 | 2011 | 1036 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2009 | 167 | 0.070 |
Why?
| | Temporal Arteries | 1 | 2008 | 47 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 237 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2010 | 275 | 0.070 |
Why?
| | Abnormalities, Multiple | 1 | 2009 | 178 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 96 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 87 | 0.070 |
Why?
| | Recurrence | 1 | 2010 | 935 | 0.070 |
Why?
| | Paraganglioma | 1 | 2008 | 47 | 0.070 |
Why?
| | Population Dynamics | 1 | 2008 | 123 | 0.070 |
Why?
| | Signal Transduction | 1 | 2020 | 4516 | 0.070 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 427 | 0.070 |
Why?
| | Gestational Age | 1 | 2009 | 760 | 0.070 |
Why?
| | Cognition Disorders | 1 | 2010 | 476 | 0.070 |
Why?
| | Forecasting | 1 | 2008 | 330 | 0.070 |
Why?
| | Health Services Needs and Demand | 1 | 2008 | 243 | 0.060 |
Why?
| | Cerebrovascular Circulation | 1 | 2008 | 221 | 0.060 |
Why?
| | Computational Biology | 2 | 2020 | 530 | 0.060 |
Why?
| | Seizures | 1 | 2008 | 340 | 0.060 |
Why?
| | Cell Survival | 2 | 2019 | 1021 | 0.060 |
Why?
| | Glasgow Coma Scale | 2 | 2018 | 153 | 0.060 |
Why?
| | Mutation | 3 | 2023 | 3346 | 0.060 |
Why?
| | Stroke | 2 | 2014 | 1022 | 0.060 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 14 | 0.060 |
Why?
| | Sex Factors | 1 | 2009 | 1715 | 0.060 |
Why?
| | Intelligence Tests | 1 | 2023 | 58 | 0.060 |
Why?
| | Cranial Irradiation | 1 | 2023 | 66 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 85 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1006 | 0.050 |
Why?
| | Abdomen | 1 | 2023 | 99 | 0.050 |
Why?
| | Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| | Narcotics | 1 | 2022 | 44 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 249 | 0.050 |
Why?
| | Catheters | 1 | 2022 | 63 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 46 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2023 | 167 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2019 | 2187 | 0.050 |
Why?
| | Vancomycin | 1 | 2022 | 75 | 0.050 |
Why?
| | Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.050 |
Why?
| | Postoperative Care | 1 | 2022 | 222 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1621 | 0.050 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 154 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2021 | 181 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 411 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2021 | 176 | 0.040 |
Why?
| | Mice | 3 | 2022 | 14872 | 0.040 |
Why?
| | Genes, APC | 1 | 2019 | 13 | 0.040 |
Why?
| | Athletes | 1 | 2022 | 328 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2387 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 314 | 0.040 |
Why?
| | Aminopyridines | 1 | 2019 | 81 | 0.040 |
Why?
| | Critical Care Nursing | 1 | 2019 | 29 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2019 | 75 | 0.040 |
Why?
| | Benzamides | 1 | 2019 | 169 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 84 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 453 | 0.040 |
Why?
| | Surgical Wound | 1 | 2018 | 18 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2019 | 130 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2013 | 1629 | 0.040 |
Why?
| | Point Mutation | 1 | 2019 | 216 | 0.040 |
Why?
| | Electronic Mail | 1 | 2018 | 54 | 0.040 |
Why?
| | Odontogenesis | 1 | 2018 | 10 | 0.040 |
Why?
| | Laser Capture Microdissection | 1 | 2018 | 23 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 850 | 0.040 |
Why?
| | Standard of Care | 1 | 2018 | 62 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 555 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 472 | 0.040 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1314 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 66 | 0.040 |
Why?
| | Prevalence | 2 | 2016 | 2251 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 78 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2017 | 23 | 0.040 |
Why?
| | Canada | 1 | 2018 | 322 | 0.040 |
Why?
| | Mucin-1 | 1 | 2017 | 18 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2017 | 34 | 0.040 |
Why?
| | Heart-Assist Devices | 1 | 2003 | 485 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 29 | 0.040 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 44 | 0.040 |
Why?
| | Machine Learning | 1 | 2021 | 316 | 0.040 |
Why?
| | Pregnancy | 1 | 2009 | 5520 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 397 | 0.040 |
Why?
| | Heart Transplantation | 1 | 2003 | 665 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 699 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 496 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2018 | 148 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2019 | 249 | 0.040 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2018 | 148 | 0.040 |
Why?
| | Treatment Failure | 1 | 2018 | 331 | 0.030 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 79 | 0.030 |
Why?
| | Neuroglia | 1 | 2018 | 150 | 0.030 |
Why?
| | Brain Diseases | 1 | 2018 | 125 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 103 | 0.030 |
Why?
| | Transcription Factors | 2 | 2017 | 1528 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2019 | 583 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1147 | 0.030 |
Why?
| | Health Surveys | 1 | 2018 | 443 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 256 | 0.030 |
Why?
| | Pyrimidines | 1 | 2019 | 376 | 0.030 |
Why?
| | Drug Synergism | 1 | 2017 | 317 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 304 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1083 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 1796 | 0.030 |
Why?
| | Software | 1 | 2020 | 530 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 386 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1694 | 0.030 |
Why?
| | Prospective Studies | 2 | 2020 | 6220 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2016 | 223 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 210 | 0.030 |
Why?
| | Animals | 3 | 2022 | 31709 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 1959 | 0.030 |
Why?
| | Quality Improvement | 1 | 2022 | 950 | 0.030 |
Why?
| | Qualitative Research | 1 | 2019 | 936 | 0.030 |
Why?
| | Illinois | 1 | 2013 | 37 | 0.030 |
Why?
| | Chicago | 1 | 2013 | 45 | 0.030 |
Why?
| | Registries | 1 | 2020 | 1768 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2017 | 591 | 0.030 |
Why?
| | Necrosis | 1 | 2013 | 211 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3004 | 0.020 |
Why?
| | Clinical Competence | 1 | 2018 | 893 | 0.020 |
Why?
| | Incidence | 1 | 2018 | 2313 | 0.020 |
Why?
| | SMARCB1 Protein | 1 | 2011 | 17 | 0.020 |
Why?
| | History, 19th Century | 1 | 2011 | 54 | 0.020 |
Why?
| | Germany | 1 | 2011 | 84 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2797 | 0.020 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2011 | 100 | 0.020 |
Why?
| | Arthritis, Juvenile | 1 | 2011 | 42 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2018 | 1395 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2363 | 0.020 |
Why?
| | History, 20th Century | 1 | 2011 | 264 | 0.020 |
Why?
| | Abducens Nerve Diseases | 1 | 2010 | 10 | 0.020 |
Why?
| | Brain Ischemia | 1 | 2014 | 299 | 0.020 |
Why?
| | Joint Dislocations | 1 | 2010 | 57 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2508 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2011 | 350 | 0.020 |
Why?
| | Clothing | 1 | 2008 | 19 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2009 | 385 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4410 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2480 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2009 | 218 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 1880 | 0.020 |
Why?
| | New York | 1 | 2003 | 106 | 0.010 |
Why?
| | Shock, Cardiogenic | 1 | 2003 | 53 | 0.010 |
Why?
| | Emergency Treatment | 1 | 2003 | 113 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 2968 | 0.010 |
Why?
| | Stroke Volume | 1 | 2003 | 504 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2003 | 776 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2003 | 617 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2003 | 712 | 0.010 |
Why?
| | Disease Progression | 1 | 2003 | 2381 | 0.010 |
Why?
| | Time Factors | 1 | 2003 | 6116 | 0.010 |
Why?
| | Heart Failure | 1 | 2003 | 1945 | 0.010 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|